IRDiRC announcement of two new Task Forces

The International Rare Diseases Research Consortium (IRDiRC) has announced the opening of two new Task Forces:

  • “Shared Molecular Etiologies Underlying Multiple Rare Diseases” aiming to address and document the existing challenges in adapting the basket trial approach used in molecularly targeted oncology clinical trials to drugs targeting shared molecular etiologies underlying multiple rare diseases.
  • “Integrating New Technologies for the Diagnosis of Rare Diseases” aiming to identify the most clinically beneficial combination(s) of metabolomic and genomic tests coupled with artificial intelligence methodologies, which would then be prioritized for development of diagnostic standards.

If you are interested in becoming a Task Force member, the call for candidates will remain open until March 1st, 2021. Please send your CV to the Scientific Secretariat of IRDiRC at scisec-irdirc(a)

The first meetings are expected to start in April 2021.

For more information regarding the Task Force objectives and the expected candidate profiles, please click here.

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit